Tertiapin

PDB_1ter_EBI.jpg

Tertiapin is a peptide toxin derived from the venom of the European honey bee (Apis mellifera). It is known for its ability to block certain types of potassium channels, specifically the inward-rectifier potassium channels (Kir channels) and calcium-activated potassium channels (SK channels).

Structure

Tertiapin is a small peptide consisting of 21 amino acids. Its sequence is as follows: Lysine-Cysteine-Lysine-Serine-Lysine-Glycine-Lysine-Cysteine-Lysine-Serine-Lysine-Glycine-Lysine-Cysteine-Lysine-Serine-Lysine-Glycine-Lysine-Cysteine-Lysine. The peptide forms a disulfide bond between the cysteine residues, which is crucial for its biological activity.

Mechanism of Action

Tertiapin exerts its effects by binding to and blocking the pore of specific potassium channels. This blockade affects the flow of potassium ions across the cell membrane, which can alter the electrical activity of the cell. The primary targets of tertiapin are the Kir3.x and Kir1.1 channels, as well as the small conductance calcium-activated potassium channels (SK channels).

Applications in Research

Due to its specific action on potassium channels, tertiapin is widely used in neuroscience and cardiology research. It helps in studying the physiological roles of these channels in various tissues, including the heart, brain, and kidney. Researchers use tertiapin to investigate the contribution of Kir and SK channels to cellular excitability, signal transduction, and other cellular processes.

Potential Therapeutic Uses

While primarily a research tool, there is interest in the potential therapeutic applications of tertiapin. By modulating potassium channel activity, tertiapin or its derivatives could be used to develop treatments for conditions such as arrhythmias, epilepsy, and hypertension. However, more research is needed to fully understand its therapeutic potential and safety profile.

See Also

• Potassium channel
• Ion channel
• Neurotoxin
• Venom

External Links

‎